Search

Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 241-249
Author(s): Dimos D. Mitsikostas,Peer Tfelt-Hansen

5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2007 Page: 235-237
Author(s): Reto M. Agosti

Journal: Current Clinical Pharmacology
Volume: 12 Issue: 1 Year: 2017 Page: 36-40
Author(s): Alphienes S. Xavier, Mageshwaran Lakshmanan, Vikneswaran Gunaseelan

Central Nervous System Acting Drugs in Treatment of Migraine Headache

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 158-172
Author(s): Mohtashem Samsam

Recent Advances in the Discovery of Selective and Non-Selective 5-HT1D Receptor Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 5 Year: 2010 Page: 479-492
Author(s): Simon E. Ward, Jeannette M. Watson

Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends

Journal: Current Vascular Pharmacology
Volume: 1 Issue: 1 Year: 2003 Page: 71-84
Author(s):

The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2017 Page: 928-938
Author(s):

5-HT1 Receptors

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3 Issue: 1 Year: 2004 Page: 1-10
Author(s): Laurence Lanfumey, Michel Hamon

[35S]GTPγS Autoradiography: A Powerful Functional Approach with Expanding Potential for Neuropharmacological Studies on Receptors Coupled to Gi Family of G Proteins

Journal: Current Neuropharmacology
Volume: 2 Issue: 2 Year: 2004 Page: 191-206
Author(s): Jarmo T. Laitinen